.Pharmacolibrary.Drugs.ATC.M.M02AA22 .Pharmacolibrary.Drugs.ATC.M.M02AA22| name: | Suxibuzone | |
| ATC code: | M02AA22 | route: | oral |
| compartments: | 1 | |
| dosage: | 600 | mg |
| volume of distribution: | 10 | L |
| clearance: | 0.6 | L/h |
| other parameters in model implementation | ||
Suxibuzone is a non-steroidal anti-inflammatory drug (NSAID) from the pyrazolone group, formerly used in the treatment of pain and inflammation in musculoskeletal disorders, particularly in animals. It acts as a prodrug of phenylbutazone and oxyphenbutazone. It is not commonly used or approved for human clinical applications today.
No published human pharmacokinetic data are available for suxibuzone; parameters estimated based on its status as a pyrazolone NSAID and as a prodrug of phenylbutazone. Estimated parameters for an oral administration in a typical adult.